Ryman Healthcare Limited (RYHTY)
Ryman Healthcare Statistics
Share Statistics
Ryman Healthcare has 202.7M shares outstanding. The number of shares has increased by 0.36% in one year.
| Shares Outstanding | 202.7M |
| Shares Change (YoY) | 0.36% |
| Shares Change (QoQ) | 0.36% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 90 |
| FTD / Avg. Volume | 50% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 660.09 and the forward PE ratio is null. Ryman Healthcare's PEG ratio is -6.69.
| PE Ratio | 660.09 |
| Forward PE | n/a |
| PS Ratio | 4.85 |
| Forward PS | n/a |
| PB Ratio | 0.71 |
| P/FCF Ratio | 6.48 |
| PEG Ratio | -6.69 |
Enterprise Valuation
Ryman Healthcare has an Enterprise Value (EV) of 18.29B.
| EV / Sales | 28.11 |
| EV / EBITDA | -360.47 |
| EV / EBIT | 27.77 |
| EV / FCF | 37.61 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.21 |
| Quick Ratio | 2.2 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | -50.64 |
| Debt / FCF | 5.28 |
| Interest Coverage | -1.38 |
Financial Efficiency
Return on Equity is 0.11% and Return on Invested Capital is 0.02%.
| Return on Equity | 0.11% |
| Return on Assets | 0.04% |
| Return on Invested Capital | 0.02% |
| Revenue Per Employee | $84,484.94 |
| Profits Per Employee | $620.13 |
| Employee Count | 7,700 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 273.21 |
Taxes
| Income Tax | -149.7M |
| Effective Tax Rate | 103.29% |
Stock Price Statistics
The stock price has increased by -37.34% in the last 52 weeks. The beta is 0.46, so Ryman Healthcare's price volatility has been higher than the market average.
| Beta | 0.46 |
| 52-Week Price Change | -37.34% |
| 50-Day Moving Average | 8.07 |
| 200-Day Moving Average | 11.87 |
| Relative Strength Index (RSI) | 25.13 |
| Average Volume (20 Days) | 180 |
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 650.53M and earned 4.78M in profits. Earnings per share was 0.03.
| Revenue | 650.53M |
| Gross Profit | -1.35M |
| Operating Income | -69.61M |
| Net Income | 4.78M |
| EBITDA | -50.73M |
| EBIT | -94.53M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 41.81M in cash and 2.57B in debt, giving a net cash position of -2.53B.
| Cash & Cash Equivalents | 41.81M |
| Total Debt | 2.57B |
| Net Cash | -2.53B |
| Retained Earnings | 3.12B |
| Total Assets | 13.08B |
| Working Capital | 451.15M |
Cash Flow
In the last 12 months, operating cash flow was 658.48M and capital expenditures -172.2M, giving a free cash flow of 486.28M.
| Operating Cash Flow | 658.48M |
| Capital Expenditures | -172.2M |
| Free Cash Flow | 486.28M |
| FCF Per Share | 0.71 |
Margins
Gross margin is -0.21%, with operating and profit margins of -10.7% and 0.73%.
| Gross Margin | -0.21% |
| Operating Margin | -10.7% |
| Pretax Margin | -22.28% |
| Profit Margin | 0.73% |
| EBITDA Margin | -7.8% |
| EBIT Margin | -10.7% |
| FCF Margin | 74.75% |
Dividends & Yields
RYHTY pays an annual dividend of $1.1, which amounts to a dividend yield of 3.71%.
| Dividend Per Share | $1.10 |
| Dividend Yield | 3.71% |
| Dividend Growth (YoY) | -10.13% |
| Payout Ratio | -305.46% |
| Earnings Yield | 0.15% |
| FCF Yield | 3.09% |
Analyst Forecast
Currently there are no analyst rating for RYHTY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 0.57 |
| Piotroski F-Score | 6 |